Matthew P. Goetz, MD
Professor of Oncology and Pharmacology
Director, Mayo Breast Cancer SPORE
Co-PI, Womens Cancer Program
Department of Medical Oncology
Matthew P. Goetz, MD, has disclosed that he has received consulting fees paid to his institution from Biotheranostics, Biovica, Context, Eagle Pharmaceuticals, Lilly, Novartis, Pfizer, and Sermonix and has received funds for research support paid to his institution from Lilly, Pfizer, and Sermonix.
Sara Hurvitz, MD
Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Sara Hurvitz, MD, FACP, has disclosed that she has received funds for research support from Ambrx, Amgen, Arvinas, AstraZeneca, Bayer, Daiichi Sankyo, Dignitana, Genentech/Roche, Gilead Sciences, GlaxoSmithKline, Immunomedics, Lilly, MacroGenics, Novartis, OBI, Pfizer, Phoenix Molecular Designs, Pieris, Puma, Radius, Sanofi, Seattle Genetics, and Zymeworks.